initial public offerings (IPOs) trading on American exchanges

Friday, May 17, 2024

Grupo Aeroméxico S.A.B. de C.V. files NYSE IPO with backing from Apollo, Delta Air Lines

Grupo Aeroméxico S.A.B. de C.V. has filed plans to go public on the New York Stock Exchange about two years after it emerged from Chapter 11.

(Reuters) - Grupo Aeroméxico SAB de CV recorded a 29% jump in revenue for 2023, the Mexican airline disclosed in its paperwork for an initial public offering in the United States on Monday, more than two years after it exited bankruptcy proceedings.
The company is among many that have flocked towards U.S. bourses in recent months as they seek to tap into the broader pool of capital and richer valuations that American markets offer.
 
The Mexico City-based carrier plans to offer American Depositary Shares under the symbol AERO with underwriters Barclays, Morgan Stanley, JPMorgan, Evercore ISI and Apollo Global Securities, according to a late Monday filing.

The company has yet to propose any financial terms for the IPO with an estimated price range, number of shares to be offered and dollar proceeds.

Mexico City-based Aeroméxico said it's "uniquely positioned" as the only full-service carrier based in Mexico and the only airline offering long-haul, widebody service connecting every major city in Mexico and 43 international cities in 22 countries.

Although the COVID-19 pandemic derailed its business and forced it into bankruptcy in 2020, Aeroméxico rang up operating income of $716 million on revenue of $4.9 billion in 2023. It reported $203 million in operating income in 2023 on revenue of $3.8 billion. 

Apollo Global Management (APO) currently owns about 22.4% of Aeroméxico's stock - or about 30.5 million shares.

Delta Air Lines Inc. (DAL) owns about 20% of the company - or 27.28 million shares.

Apollo emerged as the largest shareholder in the company after it provided a $1 billion loan to Aeroméxico as part of its debt restructuring in 2022.

About $650 million of the original principal amount was converted into equity.

Andrés Conesa Labastida, who has been chief executive of Aeroméxico since 2005, also holds a Ph.D. in economics from the Massachusetts Institute of Technology.

The company is going public during a relatively strong period for airline stocks.

The U.S. Global Jets ETF JETS is up 10.1% in 2024, compared to a 9.5% gain by the S&P 500 SPX.

Monday, May 13, 2024

IPOs this week : May 13 - 17, 24 (wk 20)

IPOs expected to price

  • Online casino gaming content provider Games Global (GGL), 
  • Chinese education services company JIADE (JDZG), 
  • and medication management firm Kindly MD (KDLY). 


IPO quiet period expirations
The analyst quiet periods end for 

  • Centuri Holdings (CTRI), 
  • Ibotta (IBTA), 
  • Tungray Technologies (TRSG), 
  • Serve Robotics (SERV), 
  • Mingteng International (MTEN), 
  • Junee (JUNE), 
  • Top Wealth Group Holding (TWG), 
  • and mF International (MFI). 

Of the group, Tungray Technologies (TRSG) has seen the biggest post-IPO share price gain.

Friday, May 10, 2024

Auna S.A. (AUNA) began trading on the NYSE on Fri 22 Mar 24

Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. 
  • Sector(s): Healthcare
  • Industry: Medical Care Facilities
  • Full Time Employees: 14,734
  • Founded in 1989 
  • HQ in Luxembourg, Luxembourg
  • https://aunainvestors.com
 AUNA Auna S.A. (NYSE) priced 30.0 mln share IPO at $12.00 per share, below the expected
$13-15 range
Opened at $9.51 

Smith Douglas Homes (SDHC) began trading on the NYSE on Thur 11 Jan 24

Smith Douglas Homes Corp. engages in the design, construction, and sale of single-family homes in the southeastern United States.
  • Sector(s): Real Estate
  • Industry: Real Estate - Development
  • Full Time Employees: 364
  • Founded in 2008 
  • Headquartered in Woodstock, Georgia
  • https://smithdouglas.com
Smith Douglas Homes priced 7.7 mln share IPO at $21.00 per share, at the high end of the $18-21 expected range.


Friday, May 3, 2024

CG Oncology (CGON) : Cretostimogene monotherapy demonstrated 75.2% complete response rate

CG Oncology announces that data from the Phase 3 BOND-003 study evaluating the
efficacy and safety of cretostimogene monotherapy in patients with high-risk Non-Muscle
Invasive Bladder Cancer unresponsive to Bacillus Calmette Guerin, showed that 75.2% of
patients achieved a complete response at any time, as of the cutoff date of April 1, 2024
IPO Jan 25, 24: CG Oncology (CGON) priced upsized 20.0 mln share IPO $19.00 per share, above the $16-18 expected range
The IPO was upsized from 17.0 mln shares, which was upsized from the original 11.8 mlnshares.
Ticker: CGON
  • Founded: 2010
  • Headquarters: Irvine, California
  • Website: cgoncology.com
  • Employees: 61